Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Rupesh Parikh

Why Ulta Beauty Stock Is Still a Buy After Earnings

Ulta Beauty stock is falling Friday after disappointing earnings, but Wall Street isn't worried. Here's what you need to know.

Kiplinger

Is Target Stock a Buy After Its Beat-And-Raise Quarter?

Target stock is soaring Wednesday after the discount retailer's blowout earnings report and analysts like what they're seeing. Here's what you need to know.

Kiplinger

Warren Buffett buys a beautifully cheap stock

His Berkshire Hathaway has climbed 24% year to date.

The Street

From analysis to the latest developments in health,
read the most diverse news in one place.

News briefs

Alleged military secret leaker Jack Teixeira ordered detained ahead of trial

Tribune News Service

‘Never did I imagine that I would have to ration chemotherapy’

Nationwide shortages of two dozen chemotherapy drugs are leading to rationing and delays in treatment for cancer patients, local and national authorities say.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.